Skip to main content

Table 1 Demographic and baseline characteristics of participants

From: The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial

 

Chitosan (n = 33)

Control (n = 33)

P-value

Age (years) mean ± SD

40.27 ± 7.20

39.00 ± 8.62

0.518*

Height (cm) mean ± SD

169.00 ± 10.19

167.63 ± 11.29

0.608*

Weight (kg) mean ± SD

87.13 ± 15.40

78.89 ± 13.87

0.026*

BMI (Kg/m2) mean ± SD

30.37 ± 3.97

28.40 ± 5.69

0.108*

Gender

 Male

18 (54.5)

13 (39.4)

0.218#

 Female

15 (45.5)

20 (60.6)

 

Marital Status

 Single

5 (15.2)

7 (21.2)

0.523#

 Married

28 (84.8)

26 (78.8)

 

Education level

 Diploma or lower

17 (51.5)

12 (36.4)

0.118#

 Bachelor

11 (33.3)

19 (57.6)

 

 Master or higher

5 (15.2)

2 (6.1)

 

Job status

 Unemployed

5 (15.2)

4 (12.1)

0.895#

 Employed

24 (72.7)

24 (72.7)

 

 Self-employed

4 (12.1)

5 (15.2)

 

Income

 Low

4 (12.1)

1 (3.0)

0.355#

 Middle

27 (81.8)

29 (87.9)

 

 High

2 (6.1)

3 (9.1)

 

NAFLD grade

 1

12 (36.4)

15 (45.5)

0.453#

 2

21 (63.6)

18 (54.5)

 
  1. BMI Body Mass Index, NAFLD Non-alcoholic Fatty Liver Disease
  2. Data are presented as n (%), otherwise it is stated
  3. *Independent sample t-test
  4. #Chi-square test
  5. P-value less than 0.05 considered significant